UB Paderborn / Katalog / Suche / in CDI

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.452-465

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Annals of oncology, 2012-05, Vol.23 (5), p.1287-1292

2012

Link zum Volltext

Verfügbarkeit prüfen

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation

Annals of oncology, 2011-06, Vol.22 (6), p.1280-1287

2011

Link zum Volltext

Verfügbarkeit prüfen

2870 Prospective evaluation of both plasma Epstein Barr Virus (EBV) DNA clearance and fludeoxyglucose-positron emission tomography (PET-CT) as a dual-endpoint in predicting early response and survival of patients undergoing chemotherapy (chemo) for advanced nasopharyngeal carcinoma (NPC) (NCT01365208)

European journal of cancer (1990), 2015-09, Vol.51, p.S580-S580

2015

Link zum Volltext

Verfügbarkeit prüfen

623: Efficacy of temsirolimus for advanced hepatocellular carcinoma (HCC) - assessment of pS6 as potential prognostic biomarker of response

European journal of cancer (1990), 2014-07, Vol.50, p.S148-S148

2014

Link zum Volltext

Verfügbarkeit prüfen

999P NPC patients with post-RT EBV clearance show a higher frequency of peripheral CD8 T-cells expressing chemo-attractant receptors at baseline and during radiation therapy

Annals of oncology, 2021-09, Vol.32, p.S848-S849

2021

Link zum Volltext

Verfügbarkeit prüfen

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii83-vii85

2012

Link zum Volltext

Verfügbarkeit prüfen

Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma

Annals of oncology, 2014-06, Vol.25 (6), p.1204-1208

2014

Link zum Volltext

Verfügbarkeit prüfen

Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy

Annals of oncology, 2020-06, Vol.31 (6), p.769-779

2020

Link zum Volltext

Verfügbarkeit prüfen

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2023-11, Vol.34, p.S1608

2023

Link zum Volltext

Verfügbarkeit prüfen

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma

Annals of oncology, 2022-08, Vol.33 (8), p.794-803

2022

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Local Failure Following Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Predominance of Within-Field Failure

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S413-S414

2007

Link zum Volltext

Verfügbarkeit prüfen

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma

Annals of oncology, 2019-06, Vol.30 (6), p.977-982

2019

Link zum Volltext

Verfügbarkeit prüfen

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma

American journal of neuroradiology : AJNR, 2020-03, Vol.41 (3), p.515-521

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx

American journal of neuroradiology : AJNR, 2020-12, Vol.41 (12), p.2339-2344

2020

Link zum Volltext

Verfügbarkeit prüfen

Institutional-based prospective molecular profiling of advanced solid tumours in Hong Kong: A report of 253 cases

Annals of oncology, 2019-11, Vol.30, p.ix124-ix125

2019

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a risk model integrating plasma Epstein-Barr virus DNA (EBV DNA) level and TNM stage for stratification of nasopharyngeal cancer (NPC) to adjuvant therapy

Annals of oncology, 2019-11, Vol.30, p.ix97-ix98

2019

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report

Annals of oncology, 2019-11, Vol.30, p.ix30

2019

Link zum Volltext

Verfügbarkeit prüfen

30P Frequency of peripheral CD8+ T cells expressing chemo-attractant receptors increases in NPC patients with EBV clearance upon radiotherapy

Immuno-oncology technology, 2022-12, Vol.16, p.100135, Article 100135

2022

Link zum Volltext

Verfügbarkeit prüfen

A pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Annals of oncology, 2018-11, Vol.29, p.ix35-ix35

2018

Link zum Volltext

Verfügbarkeit prüfen

Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation

Annals of oncology, 2016-10, Vol.27, p.vi332-vi332

2016

Link zum Volltext

Verfügbarkeit prüfen

Biomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)

Annals of oncology, 2017-11, Vol.28, p.x100-x100

2017

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms

Annals of oncology, 2009-11, Vol.20 (11), p.1854-1859

2009

Link zum Volltext

Verfügbarkeit prüfen

FGF8b oncogene mediates proliferation and invasion of Epstein―Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation

Oncogene, 2011-03, Vol.30 (13), p.1518-1530

2011

Link zum Volltext

Verfügbarkeit prüfen

Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2007-05, Vol.18 (suppl-2), p.ii67-ii68

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation

623: Efficacy of temsirolimus for advanced hepatocellular carcinoma (HCC) - assessment of pS6 as potential prognostic biomarker of response

999P NPC patients with post-RT EBV clearance show a higher frequency of peripheral CD8 T-cells expressing chemo-attractant receptors at baseline and during radiation therapy

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma

Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma

Patterns of Local Failure Following Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Predominance of Within-Field Failure

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx

Institutional-based prospective molecular profiling of advanced solid tumours in Hong Kong: A report of 253 cases

Development and validation of a risk model integrating plasma Epstein-Barr virus DNA (EBV DNA) level and TNM stage for stratification of nasopharyngeal cancer (NPC) to adjuvant therapy

A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report

30P Frequency of peripheral CD8+ T cells expressing chemo-attractant receptors increases in NPC patients with EBV clearance upon radiotherapy

A pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation

Biomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms

FGF8b oncogene mediates proliferation and invasion of Epstein―Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation

Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Suchergebnisse filtern